Ipamorelin

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that selectively stimulates the pituitary gland to release growth hormone. Its basic characteristics and mechanism of action are as follows: It is a selective agonist of the growth hormone-releasing peptide receptor (GHSR), prompting the body to secrete more growth hormone, but it typically does not significantly increase the secretion of adrenocorticotropic hormone (ACTH) or prolactin. Its early research focused on promoting gastrointestinal motility (e.g., treating postoperative intestinal obstruction or gastroparesis) and addressing growth hormone deficiency.